Antitumor effect of Culinary-Medicinal Oyster mushroom, Pleurotus ostreatus (Jacq.: Fr.) P. Kumm., derived protein fraction on tumor-bearing mice models

International Journal of Medicinal Mushrooms

Volumn 13, Issue 5, 2011, Pages 427-440

  Maiti, Swatilekha ^a   Mallick, Sanjaya K ^b   Bhutia, Sujit K ^c   Behera, Birendra ^a   Mandal, Mohitosh ^a   Maiti, Tapas K ^c  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b NMR Application Chemist   (India)

^c NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Antitumor protein; Dalton's lymphoma; Immunomodulation; Medicinal mushrooms; Pleurotus ostreatus

Indexed keywords

CIBACRON BLUE AFFINITY ELUTED PROTEIN; DOXORUBICIN; FUNGAL EXTRACT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CANCER MORPHOLOGY; CANCER TRANSPLANTATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DALTON LYMPHOMA; EX VIVO STUDY; IMMUNOMODULATION; IN VIVO STUDY; LETHAL DOSE; LYMPHOMA; MACROPHAGE; MALE; MEDICINAL MUSHROOM; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGAN WEIGHT; PLEUROTUS OSTREATUS; PROTEIN ANALYSIS; SARCOMA; SPLEEN CELL; SURVIVAL RATE; SURVIVAL TIME; TH1 CELL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR REGRESSION; WESTERN BLOTTING;

EID: 82255193306     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v13.i5.20     Document Type: Article

References (31)

1. Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol. 2001;1:364-69.
2. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushr. 2010;12:1-16.
3. Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol. 2005;67:453-68.
4. Aida FMNA, Shuhaimi M, Yazid M, Maaruf AG. Mushroom as a potential source of prebiotics: a review. Trends Food Sci Tech. 2009;20:567-75.
5. Mahajna J, Dotan N, Zaidman BZ, Petrova RD, Wasser SP. Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum. Nutr Cancer. 2009; 61:16-26.
6. Mizuno T. Bioactive biomolecules of mushrooms: food functions and medicinal effects of mushroom fungi. Food Rev Int. 1995;11:7-21.
7. Sarangi I, Ghosh D, Bhutia SK, Mallick SK, Maiti TK. Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans. Int Immunopharmacol. 2006;6:1287-97.
8. Wang HX, Ng TB. Flammulin: a novel ribosome-inactivating protein from fruiting bodies of the winter mushroom Flammulina velutipes. Biochem Cell Biol. 2000;78:699-702.
9. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: Current perspective. Int J Med Mushr. 1999;1:31-62.
10. Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol. 2007;18:4-19.
11. Chihara G. Immunopharmacology of Lentinan, a polysaccharide isolated from Lentinus edodes: its applications as a host defense potentiator. Int J Orient Med. 1992;17:57-77.
12. Bhutia SK, Mallick SK, Maiti S, Maiti TK. Inhibitory effect of Abrus abrin derived peptide fraction against Dalton's lymphoma ascites model. Phytomed. 2009;16:377-85.
13. Mallick SK, Maiti S, Bhutia SK, Maiti TK. Antitumor properties of a heteroglucan isolated from Astraeus hygrometricus on Dalton's lymphoma bearing mouse. Food Chem Toxicol. 2010;48:2115-21.
14. Li G, Kim D, Kim T, Park B. Protein-bound polysaccharide from Phellinus linteus induces G2/M phase arrest and apoptosis in SW480 human colon cancer cells. Cancer Lett. 2004;216:175-81.
15. Zhang M, Chen H, Huang J, Li Z, Zhu C, Zhang S. Effect of lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sci. 2005;76:2115-24.
16. Zhang M, Chiu LCM, Cheung PCK, Ooi, VEC. Growthinhibitory effects of a β-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell cycle arrest and apoptosis induction. Oncol Rep. 2006;15:637-43.
17. Maiti S, Bhutia SK, Mallick SK, Kumar A, Khadgi N, Kumar A, Maiti TK. Antiproliferative and immunostimulatory protein fraction from edible mushrooms. Environ Toxicol Pharmacol. 2008;26:187-91.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
19. Litchfied JT, Wilcoxon FA. Simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 1949;96:99-113.
20. Mallick SK, Maiti S, Bhutia SK, Maiti TK. Immunostimulatory properties of a polysaccharide isolated from Astraeus hygrometricus. J Med Food. 2010;13:665-72.
21. Bhutia SK, Mallick SK, Maiti TK. In vitro immunostimulatory properties of Abrus lectins derived peptides in tumor bearing mice. Phytomed. 2009;16:776-82.
22. Kane KL, Ashton FA, Schmitz JL, Folds JD. Determination of natural killer cell function by flow cytometry. Clin Diagn Lab Immunol. 1996;3:295-300.
23. Ghosh D, Maiti TK. Effects of native and heat-denatured Abrus agglutinin on tumor-associated macrophages in Dalton's lymphoma mice. Immunobiol. 2007;212:667-73.
24. Hortelano S, Bosc L. A6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes. Mol Pharmacol. 1997;51:414-21.
25. Shurin MR, Shurin GV, Lokshin A, Yurkovetsky ZR, Gutkin DW, Chatta G, Zhong H, Han B, Ferris RL. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev. 2006;25:333-56.
26. Golay J, Manganini M, Facchinetti V, Gramigna R, Broady R, Borleri G, Bernasconi S, Tedesco F, Rambaldi A, Introna M. Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2. Haematologica. 2003;88:1002-12.
27. Mocellin S, Panelli M, Wang E, Rossi CR, Pilati P, Nitti D, Lise M, Marincola FM. IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immunol. 2004;5:621-30.
28. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Bezofsky JA. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol. 2000;1:515-20.
29. Alvaro T, Cruz-Merino L, Henao-Carrasco F, Rodriguez JLV, Baz DV, Codes M, de Villena M, Provencio M. Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes. J Biomed Biotechnol. 2010;1-17.
30. Zheng LM, Ojcius DM, Garaud E, Roth C, Maxwell E, Li Z, Rong H, Chen H, Wang XY, Chatino JJ, King I. Interleukin-10 inhibits tumor metastasis through an NK celldependent mechanism. J Exp Med. 1996;184:579-84.
31. Kundu N, Beaty TL, Jackson MJ, Fulton MA. Antimetastatic and antitumor activities of interleukin-10 in a murine model of breast cancer. J Natl Cancer Inst. 1996;88:536-41.